跳至主要内容
临床试验/CTRI/2025/07/090730
CTRI/2025/07/090730尚未招募2 期

A Randomized Controlled Trial on Administration of intravenous Calcium Chloride in addition to routine Oxytocin in reducing blood loss during cesarean section

Varsha Rani1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2025年7月13日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
66
试验地点
1
主要终点
Total blood loss during cesarean section as measured by the volume of blood collected in suction containers and the weight of surgical sponges (considering 1 g of weight = 1 mL of blood).

研究概览

简要总结

This randomized trial will provide valuable information regarding whether the addition of IV calcium chloride to routine oxytocin use during cesarean sections can reduce blood loss and improve maternal outcomes. If successful, this study could provide valuable insights into adjunctive treatments to improve the management of blood loss during cesarean deliveries, potentially influencing clinical practice to enhance patient safety and reduce maternal morbidity

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • a) Women aged 18-40 years.
  • b) Women who underwent elective or emergency cesarean section at the study institution.
  • c) Singleton pregnancies with no known placental or uterine abnormalities.
  • d) Women who received either IV calcium chloride with oxytocin (group 1) or only oxytocin (group 2) as part of routine clinical management.

排除标准

  • a) Women with known allergies or contraindications to calcium chloride.
  • b) Women with pre-existing cardiac arrhythmias or significant cardiovascular disease.
  • c) Women with pre-existing coagulopathies or those who are on anticoagulant therapy.
  • d) Women with uterine anomalies, placenta previa, or other conditions that may confound blood loss.
  • e) Women who had a hysterectomy or other major surgical interventions during the cesarean.

结局指标

主要结局

Total blood loss during cesarean section as measured by the volume of blood collected in suction containers and the weight of surgical sponges (considering 1 g of weight = 1 mL of blood).

时间窗: 18 monnths

次要结局

  • Need for blood transfusion due to excessive blood loss (if applicable).
  • Uterine tone post-delivery (evaluated by the obstetrician).
  • Incidence of uterine atony, requiring additional uterotonic drugs.
  • Maternal complications: Hypotension, arrhythmias, or hypercalcemia.
  • Length of hospital stay and recovery outcomes.

研究者

发起方
Varsha Rani
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Varsha Rani

All india institute of Medical Science, Kalyani

研究点 (1)

Loading locations...

相似试验